• 2019
  • 11-14 April

III. International Expermed Congress Welcome Message

Dear Friends and Colleagues,

It is a great pleasure for us to invite you to join us in the “3rd International EXPERMED Congress” which will be held in Cyprus between April 11th – 14th, 2019.

As the world of reproductive medicine has been evolving very rapidly, EXPERMED Congress Series aim to gather key opinion leaders and experts in the field of human reproduction and assisted reproductive technologies in order to discuss the current knowledge, practice and emerging technologies which are now shaping the future of personalized reproductive medicine.  

2nd International EXPERMED Congress, which was held in Cyprus between April 27th-30th, 2017, was a huge success. With more than 30 renowned international speakers as well as over 500 participants, the meeting has already created a great interest in the region and fulfilled its goals by creating a unique environment and network to discuss and evaluate possible contributions of novel clinical, laboratory and omics-based technologies on today’s personalized reproductive medicine.  

In the 3rd International EXPERMED Congress, the focus will be the impact of these novel approaches & technologies on the diagnosis, treatment and management of difficult infertility cases through real life examples & cases, keynote lectures, and debate sessions.

The congress will be held in Bafra region of Cyprus. April in Cyprus Island is also a wonderful time to indulge yourself with the sun, the sea and the distinguished social services provided by the congress venue. For colleagues interested in more than sand and sun, Cyprus also has plenty of archaeological sites, fine Byzantine churches, monasteries and museums. It's also a wonderful place to go hiking, with an incredible wealth of natural beauties.

A more detailed information on the congress venue, scientific and social programs can be found in the congress website (www.expermedcongress.com).




Prof. Mustafa Bahçeci
Congress Chairmen

Prof. Carlos Simon
Congress Chairmen

 

 

 

 



  • 00

    DAYS

  • 00

    HOURS

  • 00

    MINUTES

  • 00

    SECONDS

III. International Expermed Congress Committees

Mustafa Bahçeci, MD.
Carlos Simon, MD., Ph.D.


 

Pre-Congress Workshops


If you wish to register or have questions related to the workshop please contact Yasemin Dervişoğlu [email protected]

 

 

Scientific Program

      Personalized Reproductive Treatment & Care: Where are we now and what does the future hold?
      Contemporary endocrinology vs. Genetics: Will the latter replace the former?
      Time-lapse reloaded: Full automation for embryo selection and improved designs
      State of the Art of PGS: how, when, and to whom?
      State of ART infertility treatment: Should it be disease vs. patient-specific?
      Personalized ART Cycle Management: Global Perspective
        Individualized Approach to Couple
        Individualized COS
        Individualized Laboratory technologies
        Individualized ET
      Translational Reproductive Science: From bench to bedside”
      Patient-specific controlled ovarian hyperstimulation: Safety while Maximizing the Results”
      Endometriosis and reproductive surgery in the 21st century
      Personalized clinical approaches in ART Failures
        Patient management aspects
        Clinical protocols aspects
        Surgical aspects
        Evidence-based/experimental aspects
      Future of ART babies: Developmental, genetic and epigenetic aspects
        Impact of clinical approaches   Laboratory aspects
        Prenatal & neonatal outcome
        ART-related epigenetic disturbances
      Improving standards in the IVF Laboratory: How far can we reach?
      Freeze-all strategy: Should all embryos go into the fridge in the near future?
      Rejuvenation of Gametes
      Mitochondrial replacement by pronuclear transfer to prevent the transmission of severe mitochondrial disease
      Clinical significance of oxidative stress and sperm DNA damage: An update
      Effect of lifestyle and environment on sperm quality: Any scope for an improvement?
      Use of Genetics in Infertility Diagnosis & Treatment
      Genetics of Male Infertility: From Bench to Bedside
      Novel Use of Genetic testing in early diagnosis in Endometriosis: fact or fiction?
      Genome engineering in the human germline and pluripotent stem cells
      Reproductive Genetics: Diagnostics and beyond
      Impact of novel genomics technologies in the future of reproductive medicine
      Embryo Mosaicism: What to do?
      Endometrial receptivity assessment: Facts and artifacts”
      Fertility preservation
      Gamete and embryo cryopreservation: What is the best strategy?
      Ovarian tissue transplantation: How far will it stay experimental?
      State of ART Clinical management in fertility preservation
      Personalizing reproductive medicine throught big data and genomics
        Emergency fertility preservation for cancer patients
        Assisted Reproductive Outcomes of Male Cancer Survivors – The latest Results
        Fertility preservation in pre-pubertal girls
        Ovarian tissue preservation: Ready for worldwide use?
        Evidence-based approaches in elective Fertility preservation: When and Whom
        Extreme medical conditions requiring fertility preservation”
      In vitro activation: A novel approach to treat infertility
15:30 - 15:50 Welcome Speech M. Bahçeci
15:50 - 16:30 Keynote Lecture I Chair: C. Ünlü
  Personalized reproductive medicine to maximize reproductive success C.Simon
16:30 - 17:50 SESSION I: NEW TECHNOLOGIES AND PERSPECTIVES IN ART Chairs: B. Urman, G. Uncu
16:30 - 16:50 Non-invasive embryo selection : Is this the future or an illusion? C. Rubio
16:50 - 17:10 Controversial issues with fresh and frozen embryo transfers G. Schattman
17:10 - 17:30 Should we use elective freezing strategies - Does and donts A. Pinborg
17:30 - 17:50 Q&A
17:50 - 18:30 Keynote Lecture II Chairs: S. Cavkaytar, E. Oral
  Molecular diagnostics in endometriosis: An update C. Becker
07:30 - 09:00 Breakfast Session I (Interactive case discussions with the experts)
Panelists: S. Ribeiro, M. Meseguer, A. Capalbo, B. Erzik, K. Vicdan
Moderator: E. Turgut
09:00 - 09:40 Keynote Lecture III Chairs: T. Çetin, R. Abalı
  Reproductive surgery in 2019: What have we achieved in 40 years? B. Urman
09:40 - 11:00 SESSION II: THE ROLE OF REPRODUCTIVE SURGERY IN DIFFICULT ART CASES Chairs: C. Demirel, C. Çelik
09:40 - 10:00 Hysteroscopic vs. laparoscopic management of the “Niche”: When to treat isthmocele? I. Argay
10:00 - 10:20 Fertility optimization by surgery: What to remove, when to remove? S. Gordts
10:20 - 10:40 Is there a place for surgery in patients with endometriosis and repeated IVF failures? J. Nassif
10:40 - 11:00 Q&A
11:00 - 11:30   Coffee Break
11:30 - 12:30
SATELLITE SYMPOSIUM (MERCK)
Choosing The Most Appropriate Gonadotropin For Your Patients
Chair: E. Oral
C. Alviggi
12:30 - 13:30   Lunch
13:30 - 14:50 SESSION III: MANAGEMENT OF DIFFICULT ART CASES THROUGH PGT-A Chairs: B. Ata, G. Karlıkaya
13:30 - 13:50 Impact of contemporary PGT-A approaches on clinical management and outcome: A global look T. Gordon
13:50 - 14:10 Effect of IVF laboratory on euploidy outcome D. Cimadomo
14:10 - 14:30 How important is to assess the genetic risk of the couple trying to conceive A. Capalbo
14:30 - 14:50 Q&A
14:50 - 15:50 DEBATE SESSION I: SUCCESFUL OUTCOME IN DIFFICULT ART CASES CAN ONLY BE ACHIEVED THROUGH Chairs: K. Boynukalın, N. Fındıklı
14:50 - 15:10 Standardization C. Alviggi
15:10 - 15:30 Personalization L. Nardo
15:30 - 15:50 Q&A
15:50 - 16:10   Coffee Break
16:10 - 16:50 Keynote Lecture IV Chairs: H. Yaralı , M. Kavrut
  How will innovation transform our current IVF practice: A glimpse from the near future D. Ezcurra
16:50 - 17:30 Keynote Lecture V Chairs: M. Bahçe, B. Demir
Assessment of gamete & embryo quality: Can mtDNA-based tests be the answer? N.Treff
07:30 - 09:00 Breakfast Session II (Interactive case discussions with the experts)
Panelists: Y. Cheong, M. Montag, K. Boynukalın, M. Işıkoğlu
Moderator: L. Karakış
09:00 - 09:40 Keynote Lecture VI Chairs: S. Özkavukcu, M. Serdaroğulları
  Stem cells in reproductive medicine: From bench to bedside X. Santamaria
09:40 - 11:00 SESSION IV: TSFP-TURKISH SOCIETY OF FERTILITY PRESERVATION SESSION Chairs: Ö. Öktem, M. Sönmezer
09:40 - 10:00 Fertility preservation: a global view H. Wallace
10:00 - 10:20 AMH in the modern era of assisted reproduction and fertility preservation R. Anderson
10:20 - 10:40 Ovarian biology: current concepts of follicle activation, folliculogenesis and artifical ovary: where are we now? E. Telfer
10:40 - 11:00 Q&A
11:00 - 11:30   Coffee Break
11:30 - 12:30
SATELLITE SYMPOSIUM (IBSA)
Dr. Google
Chair: M. Bahçeci
Y. Khalaf
12:30 - 13:30   Lunch
13:30 - 14:50 SESSION V: CONTROVERSIAL ASPECTS OF RECURRENT IMPLANTATION FAILURE Chairs: S. Sakar E. Kılıçdağ
13:30 - 13:50 Recurrent imp failure: What does it mean? Why does it happen? Y. Cheong
13:50 - 14:10 Is PGT-A the answer to recurrent implantation failure? J. Harper
14:10 - 14:30 Immune-related ART failures: From theory to reality S. Laird
14:30 - 14:50 Q&A
14:50 - 15:50 DEBATE SESSION II: OOCYTE COMPETENCY: CAN WE INTERVENE? Chairs: Ü. Göktolga, K. Özgür
14:50 - 15:10 Clinician’s perspective S. Ribeiro
15:10 - 15:30 Embryologist’s perspective M. Meseguer
15:30 - 15:50 Q&A
15:50 - 16:10   Coffee Break
16:10 - 17:30 SESSION VI: CHALLENGING ISSUES IN ANDROLOGY Chairs: T. Gürgan, E. Şerefoğlu
16:10 - 16:30 Use of sperm in difficult cases: An update M. Montag
16:30 - 16:50 Contemporary sperm selection methods: A part of the solution or a part of new problems? S. Da Silva
16:50 - 17:10 Advanced sperm DNA assessment tools: Why the facts do not fit the theory? A. Pastuszak
17:10 - 17:30 Q&A
17:30 - 18:10 Keynote Lecture VII Chairs: S. Özkavukcu, O. Olcay
  Biological, clinical and technical aspects of poor embryo quality T. Ebner
08:30 - 09:00 SESSION VII: RATIONAL USE OF MEDICINE Chairs: M. Özel, S. Çelik
08:30 - 08:45 Rational drug use in Reproductive Medicine

Presentation
N. Dinçer
08:45 - 09:00 Q&A
09:00 - 10:15 ORAL COMMUNICATIONS SESSION I Chairs: M. Özel, S. Çelik
10:15 - 10:30   Coffee Break
10:30 – 11:45 ORAL COMMUNICATIONS SESSION II Chairs: M. Bilgin, E. Yıldırım
12:00 CLOSING CEREMONY


 

III. International Expermed Congress NATIONAL SPEAKERS & CHAIRS

TBA

REGISTRATION & ACCOMMODATION

CONGRESS REGISTRATION INFORMATION

Registration Type Early Registration Before
January 11, 2019
Late Registration After
January 12, 2019
Delegate 300 Euro 350 Euro
Assistant & Nurse 200 Euro 250 Euro
Company Representative 300 Euro 350 Euro

In order to Register please contact [email protected]

The registration fees include;


  •   Admission to all scientific sessions and activities.
  •   Entry to all scientific and commercial exhibition areas.
  •   Lunches and coffee breaks indicated in the program
  •   Documents; Bag, programme and abstract book, name badge, certificate of attendance.
VAT will be added to the above rates

LIMAK CYPRUS DELUXE HOTEL BAFRA, TURKISH REPUBLIC OF NORTHERN CYPRUS

Accommodation Type Early Registration Before
January 11, 2019
Late Registration After
January 12, 2019
Single Room 625 Euro 675 Euro
Double Room (Per Person) 475 Euro 525 Euro

In order to book your Accommodation please contact [email protected]

The accommodation fees include;


  •   Accomodation fees including all inclusive for 3 nights.

TRANSFER DETAILS

The price of group transfers, which will be arranged on the arrival and departure dates of the Congress is 40 Euro per person per way.

Please contact Figur International directly for any transfer requests you may have.

ABOUT TRNC


Turkish Republic of Northern Cyprus
Cyprus being the third largest island in the Mediterranean has risen strategic, political, commercial and religious interests all through history. This charm of Northern Cyprus has provided its visitors with incomparable mystic, spiritual, comfortable and peaceful vacation. Northern Cyprus is the intersection point of Europe, Middle East, Asia and Africa. The closest neighbors are; Turkey, Southern Cyrus, Lebanon, Greece, Egypt, Israel and Syria. With its unique beach, plains and mountains, Northern Cyprus has 396 km of coast. In addition, its history and geographic location has given it a surprising synthesis of eastern and western cultures. Civilizations which date all the way back to 11 thousand years, rich multicultural heritages and relics are dispersed all around the island, which gives it an unique beauty.

Language
Northern Cyprus’s official language is Turkish. English is also being used commonly.

Religion
%99 İslam, %1 Orthodox, Maronite ve Catholic

Travel
Ercan Airport is located 12 km at the east of Northern Cyprus’s capital Lefkoşa.

Communication
International phone code is + 90 392.
Internet can be accessed through all cities, villages, hotels and cyber coffees.In addition you may use your mobile phone all through the island.

Trafic
The roads are just like in England from the left hand side. Seat belt use is mandatory. All signs and road structures are in correlation with international standards.

Currency
Turkish Lira is being used in Cyprus.You may change your currency from the hotels, banks and exchange bureaus. Majority of the credit cards can also be used.

Time
Northern Cyprus time zone: GMT + 2

Electricity
In TRNC the electrical voltage is 240 and the BS standard is used. 220/240 Volts A / C with 3 adapter is used.

Emergency Numbers

Fire 199
Police 155
Forest fire 177
Emergency medical aid 112
Coastal Security 158
Meteorology 166

Beach
Between May and October the average sea temperature is 24 C and you may access restaurants, cafeterias and bars alond with umbrellas in case of need. In addition activities like waterslide, banana, jet-ski, parasailing etc. are available.

Shopping
The most popular gifts which are purchased are; copper, silver, bronz and wodden goods, Turkish dolls, Meerschaum pipels, backgammon games, gold jewelery, leather jackets and textiles can be bought at cheap prices. Prices are stable and there is no barter exchange in Northern Cyprus. Shops are open between 8.00-13.00 and 15.30-20.00. At Sundays they are only open in the mornings. Handcrafts outside the pottery are not intended for tourists. It is against the law to remove antiques from the country.

ABSTRACT SUBMISSION



Abstract Button

Click here for the abstract book


General Guidelines

  1. 1. The abstract must contain original work, not published, submitted for presentation at a meeting of another national or international scientific organization, or submitted for publication at the time of this submission.
  2. 2. Abstracts must be approved or exempted by the appropriate Institutional Review Board (IRB) with jurisdiction or equivalent if any human subjects or any human materials were utilized.
  3. 3. A disclosure of medically related commercial and financial relationships for all authors is required.
  4. 4. Submission deadline is March 23rd, 2019 (23:59 CEST)
  5. 5. The abstract should be sent to [email protected]
  6. 6. Notification of acceptance and rejection will be emailed to the lead authors on a rolling basis.
  7. 7. Accepted abstracts will be published in the conference’s abstract book.
  8. 8. Withdrawal of abstracts can only be accepted if notified in writing and subsequently confirmed by the conference secretariat.  It is only possible to withdraw an abstract until 14 days after notification on acceptance.
  9. 9. The presenting author must be registered as an active participant. Congress Secretariat reserves the right to exclude any abstract that is not followed by a participant registration. 

Formatting Guidelines

Abstracts must follow the structure detailed below:

  1. 1. Title of the abstract (no more than 30 words)
  2. 2. Family names and full names of all authors
  3. 3. Full details of affiliation of all author(s); institution, city, country
  4. 4. Contact details of the presenting author
  5. 5. Objective: An introductory sentence indicating the objective and purpose of the study
  6. 6. Design: A briefly worded description of the study design
  7. 7. Materials and Methods: A description of experimental procedures including applicable statistical evaluation
  8. 8. Results: A summary of the new, previously unpublished data and results
  9. 9. Conclusions: A statement of the study’s conclusions
  10. 10. Support: Identify all sources of financial support for the research or state “None” if appropriate.
  11. 11. Abbreviations used in abstracts must be defined when they first appear.
  12. 12. ACCME guidelines require generic names be used for pharmaceuticals, biologics, and medical devices. The trade name of the particular product used in a study may be included in parentheses the first time the product is referenced.
  13. 13. Presenting author must be listed first.
  14. 14. Please note that the body of the abstract cannot exceed 500 words.

 

 

 

 



Scientific Secretariat


Necati Fındıklı, Ph.D.,
nfindiklibahceci.com

F. Kubra Boynukalın, M.D., M.Sc.
[email protected]



Organization Secretariat


19 Mayıs Mah. 19 Mayıs Cad. Nova Baran Center No:4 34360  Şişli / İstanbul – Türkiye
+90 212 381 46 00
+90 212 258 60 78
Yasemin Dervişoğlu / Project Manager
[email protected]


III. International Expermed. ©